Article
BAM15 Enhances Regorafenib Cytotoxicity in a Canine Osteosarcoma Cell Model
2026-08-20
Abstract excerpt
Osteosarcoma is an aggressive primary bone malignancy affecting both humans and dogs, and canine osteosarcoma represents a valuable comparative model for investigating novel therapeutic strategies. Targeting tumour metabolism may enhance the efficacy of existing anticancer treatments. This study investigated whether the mitochondrial uncoupler BAM15 sensitises canine D17 osteosarcoma cells to regorafenib. Cells we...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0eed068e-9347-5647-9ef5-c1957090eea9
- DOI
- 10.20944/preprints202608.1381.v1
